A total of 75 candidates were screened for eligibility, and 72 participants 44 breast cancer survivors and 28 non cancer patients were enrolled in the study normal dose of lasix In controlled clinical trials of AUGMENTIN XR, 25 patients received concomitant allopurinol and AUGMENTIN XR